Concert Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-18,578
| Closed | -$1.33M | – | 258 |
|
|
2017
Q1 | $1.33M | Sell |
18,578
-648
| -3% | -$46.4K | 0.3% | 94 |
|
|
2016
Q4 | $1.38M | Sell |
19,226
-13,478
| -41% | -$966K | 0.31% | 86 |
|
|
2016
Q3 | $2.6M | Buy |
32,704
+225
| +0.7% | +$17.9K | 0.32% | 65 |
|
|
2016
Q2 | $2.71M | Buy |
32,479
+6,813
| +27% | +$568K | 0.37% | 55 |
|
|
2016
Q1 | $2.36M | Sell |
25,666
-1,114
| -4% | -$102K | 0.32% | 69 |
|
|
2015
Q4 | $2.71M | Buy |
26,780
+1,533
| +6% | +$155K | 0.36% | 57 |
|
|
2015
Q3 | $2.48M | Buy |
25,247
+7,574
| +43% | +$744K | 0.34% | 59 |
|
|
2015
Q2 | $2.08M | Buy |
17,673
+419
| +2% | +$49.4K | 0.27% | 83 |
|
|
2015
Q1 | $927K | Buy |
17,254
+1,733
| +11% | +$93.1K | 0.26% | 94 |
|
|
2014
Q4 | $1.46M | Sell |
15,521
-826
| -5% | -$77.6K | 0.22% | 114 |
|
|
2014
Q3 | $1.75M | Buy |
16,347
+2,617
| +19% | +$280K | 0.24% | 60 |
|
|
2014
Q2 | $1.09M | Buy |
13,730
+203
| +2% | +$16.1K | 0.13% | 124 |
|
|
2014
Q1 | $930K | Sell |
13,527
-1,848
| -12% | -$127K | 0.12% | 147 |
|
|
2013
Q4 | $1.16M | Buy |
15,375
+341
| +2% | +$25.8K | 0.15% | 114 |
|
|
2013
Q3 | $945K | Buy |
15,034
+3,459
| +30% | +$217K | 0.13% | 123 |
|
|
2013
Q2 | $594K | Buy |
+11,575
| New | +$594K | 0.09% | 190 |
|